A retrospective study suggested that the combination of PD-1 blockade, antiangiogenic agent, pegaspargase and radiotherapy was feasible for localized NK/T cell lymphoma (36). The gene discussed is PDCD1; the disease is extranodal nasal NK/T cell lymphoma.